PharmEasy (API Holdings)
HealthTech · Online Pharmacy
Interested in this stock?
Valuation
₹3,000 – 5,000 Cr
Unlisted Price
₹5.20
52-Week Range
₹5.00 – ₹12.00
Expected IPO
2026–2027
About
India's largest online pharmacy aggregator; underwent major restructuring after valuation write-down; refocused on core pharmacy delivery and diagnostics services.
Key Highlight
Deep restructuring post-valuation crash; focus on profitability path
Financial Ratios & Metrics
Detailed financial data is not yet available for this company.
Financial disclosures for unlisted entities are limited until DRHP filing.
Share Information
IPO Details
Tags
Latest News
Auto-updated · Google NewsNews sourced from Google News RSS. Headlines link to original publishers.
More news →Frequently Asked Questions
What is the current unlisted share price of PharmEasy (API Holdings)?▾
The current indicative unlisted share price of PharmEasy (API Holdings) is ₹5.20, with a 52-week range of ₹5.00 – ₹12.00. This is a grey market price and not exchange-regulated.
When is the PharmEasy (API Holdings) IPO expected?▾
PharmEasy (API Holdings) is expected to list on Indian stock exchanges in 2026–2027. Current IPO status: Not Filed.
What is the valuation of PharmEasy (API Holdings)?▾
PharmEasy (API Holdings) is valued at approximately ₹3,000 – 5,000 Cr ($360–600M). This is a pre-IPO estimate based on grey market data and analyst reports.
What sector does PharmEasy (API Holdings) operate in?▾
PharmEasy (API Holdings) operates in the HealthTech — specifically Online Pharmacy sector. Key highlight: Deep restructuring post-valuation crash; focus on profitability path
Is PharmEasy (API Holdings) a good pre-IPO investment?▾
PharmEasy (API Holdings) is tracked on The Finance Network as a pre-IPO research subject. Key data: valuation ₹3,000 – 5,000 Cr, IPO status Not Filed, expected listing 2026–2027. This is not investment advice — always consult a SEBI-registered adviser.
Disclaimer: All data is sourced from publicly available filings, analyst reports, and grey market platforms. Unlisted share prices are indicative and not exchange-regulated. Financial ratios for unlisted companies are estimated and may differ from audited figures. This is not investment advice. Read full disclaimer →